The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Differences in clinical expression of hypertrophic cardiomyopathy associated with two distinct mutations in the beta-myosin heavy chain gene. A 908Leu----Val mutation and a 403Arg----Gln mutation.
Abstract
BACKGROUND: The disease gene for hypertrophic cardiomyopathy (HCM) has been identified as the beta-myosin heavy chain (beta-MHC) gene in some HCM families. We describe extensive clinical evaluations in two kindreds with two distinct point mutations in the beta-MHC gene. METHODS AND RESULTS: We used single-strand confirmation polymorphism (SSCP) gel analysis of polymerase chain reaction-amplified products capturing each of the 40 beta-MHC gene exons to identify distinct missense mutations in two HCM kindreds. Clinical, ECG, and echocardiographic studies were performed in the two kindreds: kindred 2755 with amino acid 908Leu----Val mutation and kindred 2002 with amino acid 403Arg----Gln mutation. The morphological appearances of HCM were similar in these two kindreds. However, the two kindreds differed with respect to disease penetrance, age of onset of disease, and incidence of premature sudden death. Twelve of 31 adults (greater than or equal to 17 years) with the disease gene in kindred 2755 did not have left ventricular hypertrophy (LVH), and only five of these had ECG abnormalities. Thus, the disease penetrance in adults with this mutation was only 61%. None of 11 children aged less than 16 years had LVH. The 908 mutation was associated with a low incidence of cardiac events: Only two sudden deaths and one syncope occurred in 46 individuals with the mutant allele. In contrast, LVH was present in all 11 adults in kindred 2002 with the 403 mutation (100% disease penetrance). In addition, three of four affected children were symptomatic and had clinical evidence of HCM. The disease in this kindred was severe and resulted in six premature sudden deaths. Seven additional patients had syncope or presyncope. CONCLUSIONS: In some kindreds, the HCM disease gene is more prevalent than indicated by echocardiography and ECG. Some point mutations may be associated with a more malignant prognosis. Preclinical identification of children with mutations associated with a high incidence of sudden death and syncope provides the opportunity to evaluate efficacy of early therapeutic interventions.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Geisterfer-Lowrance, A. A. T., Kass, S., Tanigawa, G., Vosberg, H.-P., McKenna, W., Seidman, C. E., & Seidman, J. G. (1990) · Cell · doi:10.1016/0092-8674(90)90274-i · Cited by 1,380
Cited by
Mutations in the Genes for Cardiac Troponin T and α-Tropomyosin in Hypertrophic Cardiomyopathy
Watkins, H., McKenna, W. J., Thierfelder, L., Suk, H. J., Anan, R., O'Donoghue, A., Spirito, P., Matsumori, A., Moravec, C. S., Seidman, J. G., et al. (1995) · New England Journal of Medicine · doi:10.1056/nejm199504203321603 · Cited by 937
Hypertrophic Cardiomyopathy: Clinical Spectrum and Treatment
Wigle, E. D., Rakowski, H., Kimball, B. P., & Williams, W. G. (1995) · Circulation · doi:10.1161/01.cir.92.7.1680 · Cited by 778
Niimura, H., Bachinski, L. L., Sangwatanaroj, S., Watkins, H., Chudley, A. E., McKenna, W., Kristinsson, A., Roberts, R., Sole, M., Maron, B. J., et al. (1998) · New England Journal of Medicine · doi:10.1056/nejm199804303381802 · Cited by 761
Poetter, K., Jiang, H., Hassanzadeh, S., Master, S. R., Chang, A., Dalakas, M. C., Rayment, I., Sellers, J. R., Fananapazir, L., & Epstein, N. D. (1996) · Nature Genetics · doi:10.1038/ng0596-63 · Cited by 582
Self-citationThe Molecular Genetic Basis for Hypertrophic Cardiomyopathy
Marian, A. J., & Roberts, R. (2001) · Journal of Molecular and Cellular Cardiology · doi:10.1006/jmcc.2001.1340 · Cited by 438
Frequency and Phenotypes of Familial Dilated Cardiomyopathy
Grünig, E., Tasman, J. A., Kücherer, H., Franz, W., Kübler, W., & Katus, H. A. (1998) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(97)00434-8 · Cited by 435
Familial Hypertrophic Cardiomyopathy: From Mutations to Functional Defects
Bonne, G., Carrier, L., Richard, P., Hainque, B., & Schwartz, K. (1998) · Circulation Research · doi:10.1161/01.res.83.6.580 · Cited by 425
Basso, C. (2000) · Human Pathology · doi:10.1053/hupa.2000.16659 · Cited by 418
Angiotensin-converting enzyme polymorphism in hypertrophic cardiomyopathy and sudden cardiac death
MARIAN, A. (1993) · The Lancet · doi:10.1016/0140-6736(93)92064-z · Cited by 409
Shared Genetic Causes of Cardiac Hypertrophy in Children and Adults
Morita, H., Rehm, H. L., Menesses, A., McDonough, B., Roberts, A. E., Kucherlapati, R., Towbin, J. A., Seidman, J. G., & Seidman, C. E. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa075463 · Cited by 408
McKenna, W. J., Spirito, P., Desnos, M., Dubourg, O., & Komajda, M. (1997) · Heart · doi:10.1136/hrt.77.2.130 · Cited by 307
Varnava, A. M., Elliott, P. M., Baboonian, C., Davison, F., Davies, M. J., & McKenna, W. J. (2001) · Circulation · doi:10.1161/hc3701.095952 · Cited by 297
Genetic and Molecular Basis of Cardiac Arrhythmias: Impact on Clinical Management Parts I and II
Priori, S. G., Barhanin, J., Hauer, R. N. W., Haverkamp, W., Jongsma, H. J., Kleber, A. G., McKenna, W. J., Roden, D. M., Rudy, Y., Schwartz, K., et al. (1999) · Circulation · doi:10.1161/01.cir.99.4.518 · Cited by 294
Basso, C., Calabrese, F., Corrado, D., & Thiene, G. (2001) · Cardiovascular Research · doi:10.1016/s0008-6363(01)00261-9 · Cited by 290
Anan, R., Greve, G., Thierfelder, L., Watkins, H., McKenna, W. J., Solomon, S., Vecchio, C., Shono, H., Nakao, S., & Tanaka, H. (1994) · Journal of Clinical Investigation · doi:10.1172/jci116957 · Cited by 286
Epstein, F. H., Kelly, D. P., & Strauss, A. W. (1994) · New England Journal of Medicine · doi:10.1056/nejm199403313301308 · Cited by 257
Heterologous expression of a cardiomyopathic myosin that is defective in its actin interaction
Sweeney, H. L., Straceski, A. J., Leinwand, L. A., Tikunov, B. A., & Faust, L. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)42067-9 · Cited by 203
A transgenic rabbit model for human hypertrophic cardiomyopathy
Marian, A. J., Wu, Y., Lim, D.-S., McCluggage, M., Youker, K., Yu, Q.-T., Brugada, R., DeMayo, F., Quinones, M., & Roberts, R. (1999) · Journal of Clinical Investigation · doi:10.1172/jci7956 · Cited by 181
“The high incidence of premature death in the βMyHC-Q403 rabbits is also in accord with the high incidence of SCD associated with the β-MyHC-Q403 mutation in human patients (32, 48, 49).”
Christiaans, I., van Engelen, K., van Langen, I. M., Birnie, E., Bonsel, G. J., Elliott, P. M., & Wilde, A. A. M. (2010) · EP Europace · doi:10.1093/europace/eup431 · Cited by 176
Mutation Type Is Not Clinically Useful in Predicting Prognosis in Hypertrophic Cardiomyopathy
Landstrom, A. P., & Ackerman, M. J. (2010) · Circulation · doi:10.1161/circulationaha.110.954446 · Cited by 146
CUDA, G., FANANAPAZIR, L., EPSTEIN, N. D., & SELLERS, J. R. (1997) · Journal of Muscle Research & Cell Motility · doi:10.1023/a:1018613907574 · Cited by 137
Self-citation
Metadata
- Authors
- Epstein, N. D., Cohn, G. M., Cyran, F., & Fananapazir, L.
- Venue
- Circulation
- Published
- 1992-08
- Volume
- 86
- Issue
- 2
- Pages
- 345-352
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W1990888036
- Cited by
- 230
- References
- 1
- FWCI
- 18.64
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.